Central administration of C-type natriuretic peptide (CNP) modulates food consumption in broilers: involvement of dopaminergic, melanocortinergic, and neuropeptide Y receptors
- 3 November 2025
- journal article
- research article
- Published by Springer Nature in Veterinary Research Communications
- Vol. 50 (1) , 1-13
Abstract
C-type natriuretic peptide (CNP), belonging to the natriuretic peptide group, has recently emerged as a potential modulator of feeding behavior in mammalian species. This study aimed to examine the impact of central infusion of CNP-22 on feeding behavior in neonatal broilers and to elucidate its interaction with the dopaminergic, malanocortinergic, and neuropeptide Y (NPY) systems. Across ten separate experiments, broilers were systematically allocated into four different treatment groups for each experiment. In the initial experiment, neonatal chickens (Ross-308) received ICV injections of saline or CNP-22 at escalating doses (0.75, 1.5, and 3 nmol). Subsequent experiments assessed the interplay between CNP-22 (3 nmol); L-DOPA, a precursor of dopamine; 6-hydroxydopamine (6-OHDA), a neurotoxin targeting dopaminergic neurons; SCH23390, an antagonist of D1 dopamine receptors; AMI-193, an antagonist of D2 dopamine receptors; SHU9119, an antagonist of melanocortin 3 and 4 receptors; HS 024, a selective melanocortin 4 receptor antagonist; BMS193885, an antagonist of the neuropeptide Y1 receptor; CYM9484, an antagonist of the neuropeptide Y2 receptor; and L-152,804, which functions as an antagonist at neuropeptide Y5 receptors. Treatments included individual injections and simultaneous co-administrations of CNP-22 with these pharmacological agents. Feed consumption was measured for 120 min post-infusion. When CNP-22 was administered at concentrations of 1.5 and 3 nmol, a progressive decline in meal consumption was observed, correlating with increasing dosage (P < 0.05). Co-infusion of BMS193885 + CNP-22 enhanced the anorexigenic effect induced by CNP-22 (P < 0.05). However, simultaneous infusion of 6-OHDA, SCH23390, and SHU9119 with CNP-22 markedly decreased CNP-22-induced anorexia (P < 0.05). The data indicate that CNP-22 administration suppresses feeding behavior in young broiler chickens, a process potentially mediated via the D1, MC3/MC4, and NPY1 receptors pathways. Graphical abstractKeywords
This publication has 60 references indexed in Scilit:
- Effects of central injection of liver-expressed antimicrobial peptide-2 (LEAP2) on feed intake in broiler chickens: interactions with opioidergic and serotonergic systemsVeterinary Research Communications, 2025
- Decoding the role of ghrelin and its interactions with central signaling pathways in avian appetite regulationVeterinary Research Communications, 2025
- Paracrine and endocrine pathways of natriuretic peptides assessed by ligand-receptor mapping in the Japanese eel brainCell and tissue research, 2024
- The role of central neurotransmitters in appetite regulation of broilers and layers: similarities and differencesVeterinary Research Communications, 2024
- The Crosstalk Between Brain Mediators Regulating Food Intake Behavior in Birds: A ReviewInternational Journal of Peptide Research and Therapeutics, 2021
- Modulatory function of NMDA glutamate receptor on MC3/MC4 receptors agonist-induced hypophagia in neonatal meat-type chickenVeterinary Research Communications, 2017
- Dopamine-induced hypophagia is mediated by D1 and 5HT-2c receptors in chickenVeterinary Research Communications, 2013
- Central manipulation of dopamine receptors attenuates the orexigenic action of ghrelinPsychopharmacology, 2013
- Isolation and identification of C-type natriuretic peptide in chicken brainBiochemical and Biophysical Research Communications, 1991
- Gene and precursor structure of porcine C-type natriuretic peptideBiochemical and Biophysical Research Communications, 1990